Apotex Inc.

Cases where party is a Patent Asserter

Displaying 1 - 3 of 3

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 101 - 125 of 125
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
101 Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al 1:17-cv-00990 D.Del.
  • 8 Product company
Cilag GMBH International
102 Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al 1:17-cv-00990 D.Del.
  • 8 Product company
Mitsubishi Tanabe Pharma Corp.
103 Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al 1:17-cv-00990 D.Del.
  • 8 Product company
Janssen Pharmaceuticals, Inc.
104 Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al 1:17-cv-00990 D.Del.
  • 8 Product company
Janssen Pharmaceutica
105 Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al 1:17-cv-00990 D.Del.
  • 8 Product company
Janssen Research & Development LLC
106 MERCK SHARP & DOHME CORP. v. APOTEX INC. et al 3:17-cv-05399 D.N.J.
  • 8 Product company
Merck Sharp & Dohme Corp.
107 Onyx Therapeutics, Inc. v. Apotex Inc. et al 1:17-cv-01202 D.Del.
  • 8 Product company
Onyx Therapeutics, Inc.
108 BIAL - PORTELA & CA S.A. et al v. Apotex Inc. et al 1:18-cv-00382 D.Del.
  • 8 Product company
Bial - Holding, S.A.
109 BIAL - PORTELA & CA S.A. et al v. Apotex Inc. et al 1:18-cv-00382 D.Del.
  • 8 Product company
Sunovion Pharmaceuticals Inc.
110 BIAL - PORTELA & CA S.A. et al v. Apotex Inc. et al 1:18-cv-00382 D.Del.
  • 8 Product company
Bial - Portela & CA S.A.
111 ASTRAZENECA PHARMACEUTICALS LP et al v. APOTEX INC. et al 1:18-cv-11238 D.N.J.
  • 8 Product company
Astrazeneca AB
112 ASTRAZENECA PHARMACEUTICALS LP et al v. APOTEX INC. et al 1:18-cv-11238 D.N.J.
  • 8 Product company
Astrazeneca, UK Limited
113 ASTRAZENECA PHARMACEUTICALS LP et al v. APOTEX INC. et al 1:18-cv-11238 D.N.J.
  • 8 Product company
Astrazeneca Pharmaceuticals LP
114 Novartis Pharmaceuticals Corporation v. Apotex Inc., et al. 1:18-cv-01038 D.Del.
  • 8 Product company
Novartis Pharmaceuticals Corporation
115 Bayer Healthcare LLC et al v. Apotex Inc. et al 1:18-cv-01539 D.Del.
  • 8 Product company
Onyx Pharmaceuticals, Inc.
116 Bayer Healthcare LLC et al v. Apotex Inc. et al 1:18-cv-01539 D.Del.
  • 8 Product company
Bayer Healthcare Pharmaceuticals Inc.
117 Bayer Healthcare LLC et al v. Apotex Inc. et al 1:18-cv-01539 D.Del.
  • 8 Product company
Bayer Healthcare LLC
118 Apotex Inc. v. Gilead Sciences, Inc. et al 3:18-cv-06475 N.D.Cal.
  • 8 Product company
Gilead Sciences, Inc.
119 Apotex Inc. v. Gilead Sciences, Inc. et al 3:18-cv-06475 N.D.Cal.
  • 8 Product company
Astellas Pharma US, Inc.
120 Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al 1:18-cv-01673 D.Del.
  • 8 Product company
Anacor Pharmaceuticals, Inc.
121 CELGENE CORPORATION v. APOTEX INC. 2:18-cv-16395 D.N.J.
  • 8 Product company
Celgene Corporation
122 Horizon Medicines LLC et al v. Apotex Inc. et al 1:22-cv-00640 D.Del.
HZNP Finance LTD.
123 Horizon Medicines LLC et al v. Apotex Inc. et al 1:22-cv-00640 D.Del.
HZNP Medicines LLC
124 Horizon Medicines LLC et al v. Apotex Inc. et al 1:22-cv-00640 D.Del.
Horizon Medicines LLC
125 Horizon Medicines LLC et al v. Apotex Inc. et al 1:22-cv-00640 D.Del.
Horizon Therapeutics Ireland DAC